Moderna’s combination skin cancer therapy receives FDA’s breakthrough tag
Moderna Inc said on Wednesday its experimental personalized mRNA skin cancer vaccine in combination with Merck & Co Inc’s drug Keytruda has received breakthrough therapy designation from US regulators as an additional treatment for high risk patients. Shares of Moderna rise 2.5% to $164 after the market. The breakthrough tag is granted by the US […]
The post Moderna’s combination skin cancer therapy receives FDA’s breakthrough tag appeared first on Inquirer News.
Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Money Nations does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.